Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets. (STAK)
Strategies to Augment Ketosis: Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- BMI >27 and =35 kg/m2
Exclusion Criteria:
- have diabetes, liver, kidney, or other metabolic or endocrine dysfunction, or using diabetic medications.
- Currently consuming a low-carbohydrate diet
- Weight loss of >10% in past 6 months -Currently pregnant or nursing, or planning to become pregnant during the study
- Major psychiatric disorder (e.g., schizophrenia, bipolar disorder)
- Excessive alcohol intake (acute or chronic) defined as average consumption of 3 or more alcohol-containing beverages daily or consumption of more than 14 alcoholic beverages per week
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Ketogenic Diet
Participants will have all their meals prepared in the Instructional Kitchen in the Ohio Union, irrespective of group assignment.
They will receive a daily caloric intake equal to 75% of their estimated requirement to maintain weight, which should result in weight loss over the 6-week period.
For those in the ketogenic groups, daily macronutrient intake will consist of 35 g of carbohydrates and moderate protein calculated as 1.5 g/kg of reference weight.
The remaining caloric intake will consist of fat.
A wide range of whole foods will be incorporated into the meals, including non-starchy vegetables, meats, nuts and seeds, oils, cheese, butter, cream, and eggs.
The menu will be shared with participants prior to enrolling in the study so they know what to expect in terms of the meal plans.
|
DEXA Scanning will be done pre-, mid-, and post- intervention.
The diet intervention will start after all baseline testing is complete
Blood samples will be collected biweekly.
Hand-held glucometer will be used daily to monitor dietary intervention adherence.
24 hour urine collection will be done biweekly.
The first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM).
This cognitive battery is a library of computer-based tests of domains including attention, concentration, reaction time, memory, processing speed, decision-making, and executive function.
|
|
Experimental: Ketogenic Diet + Ketone Salt
Participants will have all their meals prepared in the Instructional Kitchen in the Ohio Union, irrespective of group assignment.
They will receive a daily caloric intake equal to 75% of their estimated requirement to maintain weight, which should result in weight loss over the 6-week period.
For those in the ketogenic groups, daily macronutrient intake will consist of 35 g of carbohydrates and moderate protein calculated as 1.5 g/kg of reference weight.
The remaining caloric intake will consist of fat.
A wide range of whole foods will be incorporated into the meals, including non-starchy vegetables, meats, nuts and seeds, oils, cheese, butter, cream, and eggs.
The menu will be shared with participants prior to enrolling in the study so they know what to expect in terms of the meal plans.
This group will also be provided a ketone salt supplement to take x2 daily.
|
DEXA Scanning will be done pre-, mid-, and post- intervention.
The diet intervention will start after all baseline testing is complete
Blood samples will be collected biweekly.
Hand-held glucometer will be used daily to monitor dietary intervention adherence.
24 hour urine collection will be done biweekly.
The first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM).
This cognitive battery is a library of computer-based tests of domains including attention, concentration, reaction time, memory, processing speed, decision-making, and executive function.
|
|
Active Comparator: Low Fat Diet +Placebo
The low-fat comparison group will also be provided all their food.
Their diet will also be restricted in calories and have the same level of protein, but it will be lower in fat and higher in carbohydrate.
The low-fat diet will consist of approximately 25% fat, with the remaining calories coming from carbohydrates (approximately 55% after accounting for protein at around 20%).
Added sugars will be kept relatively low (less than 25 g/day) with a focus on unprocessed carbohydrate-rich foods.
Saturated fat will be limited to less than 10% of total energy, with a focus on unsaturated fat sources.
|
DEXA Scanning will be done pre-, mid-, and post- intervention.
The diet intervention will start after all baseline testing is complete
Blood samples will be collected biweekly.
Hand-held glucometer will be used daily to monitor dietary intervention adherence.
24 hour urine collection will be done biweekly.
The first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM).
This cognitive battery is a library of computer-based tests of domains including attention, concentration, reaction time, memory, processing speed, decision-making, and executive function.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily Ketone/Glucose Monitoring
Time Frame: Up to 6 weeks
|
Daily fasting glucose/ketones will be assessed using capillary finger stick lancing.
A small drop of blood will be obtained once daily, while fasting, using enzymatic strips fitted for a handheld analyzer (KetoMojo).
All the data will be stored in the device's internal memory.
|
Up to 6 weeks
|
|
Cholesterol (mg/dl)
Time Frame: up to six weeks
|
Fasting venous blood will be collected biweekly to measure cholesterol.
|
up to six weeks
|
|
Insulin (mIU/L)
Time Frame: up to six weeks
|
Fasting venous blood will be collected biweekly.
|
up to six weeks
|
|
Glucose (mg/dL)
Time Frame: up to six weeks
|
Fasting venous blood will be collected biweekly.
|
up to six weeks
|
|
Lean Mass (kg)
Time Frame: up to six weeks
|
DEXA Scanning will be biweekly to assess lean mass
|
up to six weeks
|
|
Fat Mass (kg)
Time Frame: up to six weeks
|
DEXA Scanning will be biweekly to assess fat mass
|
up to six weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neuropsychological Outcome 1 - Reaction time (Throughput)
Time Frame: up to six weeks
|
The first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM).
Measures SRT by presenting the user with a series of "*" symbols to which they must respond as quickly as possible each time the symbol appears.
Results are measured by throughput.
|
up to six weeks
|
|
Neuropsychological Outcome 1 - Visual Short Term Memory (Throughput)
Time Frame: up to six weeks
|
The first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM).
Measures verbal short-term memory by having the users memorize a set of characters and then indicate as single characters are presented on the screen whether the character was part of the memory set.
Results are measured by throughput.
|
up to six weeks
|
|
Neuropsychological Outcome 1 - Spatial Processing (Throughput)
Time Frame: up to six weeks
|
The first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM).
Measures visual spatial skills and mental rotation by having the users compare the equivalence of two 4-bar histograms, the first of which is displayed upright and the second of which is displayed after a 90° rotation either clockwise or counterclockwise.
Results are measured by Throughput.
|
up to six weeks
|
|
Urine Chemistries
Time Frame: up to 6 weeks
|
24 hour urine will be collected biweekly and analyzed for urine chemistries
|
up to 6 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jeff Volek, Phd, Ohio State University
Publications and helpful links
General Publications
- Kackley ML, Brownlow ML, Buga A, Crabtree CD, Sapper TN, O'Connor A, Volek JS. The effects of a 6-week controlled, hypocaloric ketogenic diet, with and without exogenous ketone salts, on cognitive performance and mood states in overweight and obese adults. Front Neurosci. 2022 Sep 30;16:971144. doi: 10.3389/fnins.2022.971144. eCollection 2022.
- Belany P, Kackley ML, Zhao S, Kluwe B, Buga A, Crabtree CD, Nedungadi D, Kline D, Brock G, Simonetti OP, Volek JS, Joseph JJ. Effects of Hypocaloric Low-Fat, Ketogenic, and Ketogenic and Ketone Supplement Diets on Aldosterone and Renin. J Clin Endocrinol Metab. 2023 Jun 16;108(7):1727-1739. doi: 10.1210/clinem/dgad009.
- Buga A, Kackley ML, Crabtree CD, Bedell TN, Robinson BT, Stoner JT, Decker DD, Hyde PN, LaFountain RA, Brownlow ML, O'Connor A, Krishnan D, McElroy CA, Kraemer WJ, Volek JS. Fasting and diurnal blood ketonemia and glycemia responses to a six-week, energy-controlled ketogenic diet, supplemented with racemic R/S-BHB salts. Clin Nutr ESPEN. 2023 Apr;54:277-287. doi: 10.1016/j.clnesp.2023.01.030. Epub 2023 Feb 4.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2017H0395
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.